29.34
3.35%
0.95
Handel nachbörslich:
29.34
Finanzdaten der Dyne Therapeutics Inc-Aktie (DYN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.17%
69.16
|
67.69 | 62.27 | 66.74 | 45.46 |
Operating Income/Loss |
2.17%
-69.16
|
-67.69 | -62.27 | -66.74 | -45.46 |
Income/Loss From Continuing Operations Before Tax |
1.48%
-65.65
|
-66.64 | -60.21 | -64.90 | -44.19 |
Income/Loss From Continuing Operations After Tax |
1.48%
-65.65
|
-66.64 | -60.21 | -64.90 | -44.19 |
Net Income/Loss
|
1.48%
-65.65
|
-66.64 | -60.21 | -64.90 | -44.19 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Earnings Per Share |
25.69%
-0.81
|
-1.09 | -0.99 | -1.08 | -0.78 |
Diluted Earnings Per Share |
25.69%
-0.81
|
-1.09 | -0.99 | -1.08 | -0.78 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):